Cellectar Biosciences Inc. – Plans of Reorganization, Merger, Acquisition or Similar

NASDAQ: CLRB
Share price (11/10/26): $1.22
Market cap (11/10/26): $11.5 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

from SC 13D/A 21 pages Series C-2016 Common Stock Purchase Warrant Cellectar Biosciences, Inc

from 8-K 62 pages Agreement and Plan of Merger Dated as of April 8, 2011 by and Among Novelos Therapeutics, Inc., Cell Acquisition Corp., and Cellectar, Inc

from 10QSB ~5 pages Agreement and Plan of Merger

from 8-K ~5 pages Plan of reorganization, merger, acquisition or similar